Navigation Links
AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
Date:2/3/2009

New York, Feb. 3 /PRNewswire-FirstCall/ -- AngioGenex Inc. (OTC Bulletin Board: AGGX.OB) is a New York-based biotechnology company that is pioneering the targeting of Id genes and proteins for the discovery and development of anti-angiogenic drugs to treat cancer. Today the Company announced that it presented animal data at two recent scientific meetings that demonstrate the ability of its lead small molecule candidate drug AGX51 to mitigate tumor formation and metastases.

Dr. Robert Benezra, the scientific founder of AngioGenex and Head of the Company's Scientific Advisory Board presented at the Keystone Symposium held January 1-6 in Big Sky, Montana on Angiogenesis and Lymphangiogenesis in Cancer, and Dr. William Garland, the Company's CEO, presented at the PepTalk meeting held January 11-16 in San Diego, California.

Besides AGX51, both speakers also touted the continually emerging importance of Id in the development and progression of cancer and the therapeutic potential of the novel, anti-Id oligonucleotides invented by Dr. Benezra. An initial report on one of these oligonucleotides (AGX1053) appeared last year in Nature Biotechnology 2008; 26: 91-100.

AngioGenex is currently pursuing the preclinical development of its small, patented molecules and oligonucleotides that have potent anti-angiogenic / anti-tumor activity through inhibition of the action of the Id proteins. The Chairman of the Board of AngioGenex, Dr. Richard Salvador, commented that "information accruing on the control of new blood vessel formation into tumors by the Id genes and proteins confirms that drugs that inhibit their activity, such as AGX1053 and AGX51, are the first in a class of new and unique anti-tumor agents. With sufficient funding we plan to have both drugs in man in 9 to 12 months. Our technology offers a potentially more effective and, therefore, a more cost effective anti-angiogenic based therapy for cancer tha
'/>"/>

SOURCE AngioGenex Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. William Garland Joins AngioGenexs New Board of Directors
2. AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
3. AngioGenex Reviews 2008 Achievements and Sets Goals for 2009
4. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
5. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
7. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
8. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
9. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
10. Arpida Presents Preclinical Data on AR-2474 at ICAAC
11. Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014  Next month, executives from clinical trial ... industry events beginning with Patient-Centered Clinical Trials 2014 , ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits of ... of tactics – from media to mobile apps – can ...
(Date:8/28/2014)... Sterlitech is proud to announce that it is ... of products . These additional products increase the ... filters with surface charges. , “We have ... membrane process testing equipment, and correspondingly, a wider demand ... Sterlitech President Mark Spatz. “The addition of Synder ...
(Date:8/28/2014)... Florida State University research team has led to a ... white light, and convert photon energy directly to mechanical ... , Biwu Ma, associate professor in the Department of ... Engineering, created the molecule in a lab about a ... creation has many other unique capabilities. , For example, ...
(Date:8/28/2014)... A new market research report ... available from Strategic Consulting, Inc., the leading information ... Market Review, Fourth Edition: Global Review of Microbiology ... and compares microbiology test volumes, market values and ... Asia, and forecasts future volumes and market values ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Sterlitech Corporation Enhances Its Selection of Flat Sheet Membrane Filters 2Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3
... Third Wave Technologies Inc. has announced that the southwestern ... Wave's Invader Hepatitis C Virus genotyping reagents. , ,The reagents ... of the Hepatitis C virus, a blood-transmitted disease estimated to ... percent of those infected do not know it, according to ...
... Mountain States Health Alliance , a regional health care ... the Milwaukee-based Johnson Controls, Inc. , for system-wide ... System will be installed throughout the health care system, ... for a variety of voice and data services. , ...
... CHICAGO So you snagged a job offer from one of ... This is a big step. Think of it as getting an ... the gratification we all feel when we are wanted (not to ... unemployed) can at times overwhelm our good judgment. , ,Taking a ...
Cached Biology Technology:Tennessee health care system to install Johnson Controls wireless tech 2Ten red flags in your Midwest technology offer letter 2Ten red flags in your Midwest technology offer letter 3Ten red flags in your Midwest technology offer letter 4Ten red flags in your Midwest technology offer letter 5
(Date:8/28/2014)... northern California, and Alaska totaled 515 million board feet ... increase of more than 10 percent compared to the ... Northwest Research Station reported today. During this same period, ... 247 million board feet. , The total value of ... to $390 million in the same quarter, while the ...
(Date:8/28/2014)... Ludwig-Maximilians-Universitaet (LMU) in Munich have assigned a number ... predatory arthropods. These animals lived in shallow marine ... forms found in Jurassic strata. , Before ... marine habitat and were fossilized some 435 million ... of the Silurian seas although they were ...
(Date:8/27/2014)... mechanical force that a single fungal cell or bacterial colony ... it plays a heavy role in setting up some of ... may not be too much of a stretch to say ... ability to respond to the touch of beneficial fungi, according ... of agronomy at the University of Wisconsin-Madison. , "Many ...
Breaking Biology News(10 mins):West coast log exports up, lumber exports down in second quarter of 2014 2Paleontology: Oldest representative of a weird arthropod group 2A touching story: The ancient conversation between plants, fungi and bacteria 2A touching story: The ancient conversation between plants, fungi and bacteria 3
... by scientists at The University of Texas Medical School ... vascular smooth-muscle cells in people who suffer from hereditary ... warning in the prime of their lives. Thoracic ... dissections, is the 15th leading cause of death in ...
... appealed for more information on the worlds biodiversity to ... to understand the impact of climate change on the ... by the Biotechnology and Biological Sciences Research Council (BBSRC), ... and computer scientists at the University of Cardiff, has ...
... Researchers at Childrens Hospital of Pittsburgh of UPMC are participating ... effectiveness of oral insulin in preventing or delaying the onset ... disease. The researchers want to determine if one insulin ... type 1 diabetes in relatives of people who are found ...
Cached Biology News:Life-threatening gene defect located by UT-Houston researchers 2Life-threatening gene defect located by UT-Houston researchers 3Life-threatening gene defect located by UT-Houston researchers 4How global is the Global Biodiversity Information Facility? 2Children's Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes 2
... every research laboratory, the revolutionary Luminex 100 ... inexpensively and in real time enhancing your ... system includes the Luminex 100, the XY ... technology which enables you to simultaneously assay ...
... source of amino acids and peptides ... casein. It is recommended for laboratory ... used in antibiotics, toxins and enzyme ... microbiology pH6.8 0.5 at 25 C, ...
... Human Hep G2 cells were cultured in ... and harvested at the log phase of growth. ... their native forms, cells were fixed in acetone-methanol. ... (5 mm) adhesive coated slide, with each wells ...
... cultured in Minimum Essential Medium (Eagle) with 2 ... of growth. In order to keep the ... in acetone-methanol. The cells are arrayed on ... each wells surface specifically treated to enhance cellular ...
Biology Products: